Literature DB >> 35999482

The medicalization of testosterone: reinventing the elixir of life.

Thiago Gagliano-Jucá1, Mauricio Alvarez2, Shehzad Basaria3.   

Abstract

The pursuit of longevity, which during the Renaissance era was limited to longing for miraculous ways of rejuvenation, such as bathing in the fountain of youth, took a scientific turn in 1889 with the publication of Brown-Sequard's self-experiments with an extract of animal testes, which apparently improved his vitality, physical strength and cognition. This extract, marketed then as the "Elixir of Life", was sold for decades throughout Europe and North America. However, recent replication of Brown-Sequard's experiments demonstrated that such an extract only contains homeopathic concentrations of testosterone that are insufficient to exert any biological effect. Thus, the birth of Andrology began with a placebo effect. Over the past few decades, the quest for compounds that might lead to rejuvenation has regained traction, with testosterone being at the forefront. Though clinical practice guidelines advocate testosterone therapy in men with organic hypogonadism-the only indication approved by the Food and Drug Administration-testosterone continues to be marketed as a wonder drug with rejuvenating effects on sexual function, vitality, and a host of other unproven benefits. Additionally, the epidemic of obesity and diabetes, conditions associated with low testosterone, has further brought testosterone into the limelight. Although the number of testosterone prescriptions written have increased several-fold in the past two decades, carefully conducted randomized trials suggest modest benefits of testosterone therapy. At the same time, safety concerns, particularly in older men, remain valid.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Aging; Anabolic steroids; Diabetes; Obesity

Year:  2022        PMID: 35999482     DOI: 10.1007/s11154-022-09751-8

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   9.306


  61 in total

1.  Brown-Séquard revisited: a lesson from history on the placebo effect of androgen treatment.

Authors:  Andrea J Cussons; Chotoo I Bhagat; Stephen J Fletcher; John P Walsh
Journal:  Med J Aust       Date:  2002 Dec 2-16       Impact factor: 7.738

2.  Organotherapy, British physiology, and discovery of the internal secretions.

Authors:  M Borell
Journal:  J Hist Biol       Date:  1976       Impact factor: 1.326

Review 3.  History and epidemiology of anabolic androgens in athletes and non-athletes.

Authors:  Gen Kanayama; Harrison G Pope
Journal:  Mol Cell Endocrinol       Date:  2017-03-01       Impact factor: 4.102

4.  The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates.

Authors:  Harrison G Pope; Gen Kanayama; Alison Athey; Erin Ryan; James I Hudson; Aaron Baggish
Journal:  Am J Addict       Date:  2013-09-20

Review 5.  The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis.

Authors:  Dominic Sagoe; Helge Molde; Cecilie S Andreassen; Torbjørn Torsheim; Ståle Pallesen
Journal:  Ann Epidemiol       Date:  2014-01-30       Impact factor: 3.797

Review 6.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

7.  Testosterone secretion and metabolism in male senescence.

Authors:  A Vermeulen; R Rubens; L Verdonck
Journal:  J Clin Endocrinol Metab       Date:  1972-04       Impact factor: 5.958

8.  Evolving ideals of male body image as seen through action toys.

Authors:  H G Pope; R Olivardia; A Gruber; J Borowiecki
Journal:  Int J Eat Disord       Date:  1999-07       Impact factor: 4.861

9.  Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.

Authors:  Shalender Bhasin; Juan P Brito; Glenn R Cunningham; Frances J Hayes; Howard N Hodis; Alvin M Matsumoto; Peter J Snyder; Ronald S Swerdloff; Frederick C Wu; Maria A Yialamas
Journal:  J Clin Endocrinol Metab       Date:  2018-05-01       Impact factor: 5.958

10.  Kinetics of removal of intravenous testosterone pulses in normal men.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Peter Y Liu; Paul Y Takahashi
Journal:  Eur J Endocrinol       Date:  2010-01-20       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.